• Non ci sono risultati.

Rectal Cancer Treatment

N/A
N/A
Protected

Academic year: 2022

Condividi "Rectal Cancer Treatment"

Copied!
6
0
0

Testo completo

(1)

Recent Results

in Cancer Research

165

Managing Editors

P.M. Schlag, Berlin · H.-J. Senn, St. Gallen

Associate Editors

P. Kleihues, Zürich · F. Stiefel, Lausanne B. Groner, Frankfurt · A. Wallgren, Göteborg

Founding Editor

P. Rentchnik, Geneva

(2)

M.W. Büchler · R.J. Heald · B. Ulrich J. Weitz (Eds.)

Rectal Cancer Treatment

With 56 Figures and 64 Tables

123

(3)

Prof. Dr. med. Dr. h.c. Markus W. Büchler PD Dr. med. Jürgen Weitz

Chirurgische Universitätsklinik Heidelberg

Abteilung für Allgemeine, Viszerale, Unfallchirurgie und Poliklinik Im Neuenheimer Feld 110

69120 Heidelberg, Germany Prof. Dr. med. Bernward Ulrich Chirurgie, Krankenhaus Gerresheim Kliniken der Landeshauptstadt Gräulinger Straße 120 40625 Düsseldorf, Germany

Professor Richard John Heald OBE Surgical Director

The Pelican Cancer Foundation North Hampshire Hospital Basingstoke, Hampshire RG24 9NA, UK

Indexed in Current Contents and Index Medicus

ISBN 3-540-23341-5 Springer Berlin Heidelberg New York ISSN 0080-0015

Library of Congress Control Number: 2005920528

Bibliographic information published by Die Deutsche Bibliothek

Die Deutsche Bibliothek lists this publication in the Deutsche Nationalbibliografie;

detailed bibliographic data is available in the Internet at <http: dnd.ddb.de>.

This work is subject to copyright. All rights reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustra- tions, recitation, broadcasting, reproduction on microfilm or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provisions of the German Copyright Law of September, 9, 1965, in its current version, and permission for use must always be obtained from Springer-Verlag. Violations are liable for prosecution under the German Copyright Law.

Springer is a part of Springer Science+Business Media springeronline.com

© Springer-Verlag Berlin Heidelberg 2005

The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use.

Product liability: The publisher cannot guarantee the accuracy of any information about dosage and application contained in this book. In every individual case the user must check such information by consulting the relevant literature.

Editor: Dr. Ute Heilmann, Heidelberg, Germany

Desk editor: Dörthe Mennecke-Bühler, Heidelberg, Germany

Typesetting and Production: LE-TEX Jelonek, Schmidt & Vöckler GbR, Leipzig Cover design: design&production GmbH, 69121 Heidelberg, Germany Printed on acid-free paper 21 3150 YL – 5 4 3 2 1 0

(4)

Contents

Postoperative Pathophysiology and Choice of Incision . . . . 1 Richard P. Billingham

Fast-Track Colonic Surgery: Status and Perspectives . . . . 8 Henrik Kehlet

Fast-Track Surgery: The Heidelberg Experience . . . . 14 M. Kremer, A. Ulrich, M. W. Büchler, W. Uhl

Rectal Cancer: A Compartmental Disease.

The Mesorectum and Mesorectal Lymph Nodes . . . . 21 Susan Galandiuk, Kiran Chaturvedi, Boris Topor

The Pathological Assessment of Total Mesorectal Excision:

What Are the Relevant Resection Margins? . . . . 30 Frank Autschbach

Is the Lateral Lymph Node Compartment Relevant? . . . . 40 Moritz Koch, Peter Kienle, Dalibor Antolovic,

Markus W. Büchler, Jürgen Weitz

Diagnostics of Rectal Cancer: Endorectal Ultrasound . . . . 46 Hanns-Peter Knaebel, Moritz Koch, Tobias Feise,

Axel Benner, Peter Kienle

Preoperative Staging of Rectal Cancer: The MERCURY Research Project . . . 58 G. Brown, I. R. Daniels

Rectal Cancer Management: Europe Is Ahead . . . 75 R. J. Heald, I. Daniels

Teaching Efforts to Spread TME Surgery in Sweden . . . . 82 Lars Påhlman, Urban Karlbom

Learning Curve: The Surgeon as a Prognostic Factor

in Colorectal Cancer Surgery . . . . 86 Pietro Renzulli, Urban T. Laffer

(5)

VI Contents

Surgical Results of Total Mesorectal Excision

for Rectal Cancer in a Specialised Colorectal Unit . . . 105 KokSun Ho, Francis Seow-Choen

Total Mesorectal Excision: The Heidelberg Results after TME . . . 112 Alexis Ulrich, Jan Schmidt, Jürgen Weitz, Markus W. Büchler

Is Local Excision of T2/T3 Rectal Cancers Adequate? . . . 120 D. L. Beral, J. R. T. Monson

Operative Treatment of Locally Recurrent Rectal Cancer . . . 136 Johan N. Wiig, Stein G. Larsen, Karl-Erik Giercksky

Laparoscopic TME: Better Vision, Better Results? . . . 148 T. H. K. Schiedeck, F. Fischer, C. Gondeck, U. J. Roblick,

H. P. Bruch

Laparoscopic TME – The Surgeon’s or the Patient’s Preference . . . 158 J. Göhl, S. Merkel, W. Hohenberger

Laparoscopic Total Mesorectal Excision – The Turin Experience . . . 167 M. Morino, G. Giraudo

Evacuation of Neorectal Reservoirs after TME . . . 180 J. S. Köninger, M. Butters, J. D. Redecke, K. Z’graggen

Long-Term Functional Results

After Straight or Colonic J-Pouch Coloanal Anastomosis . . . 191 Guillaume Portier, Ivan Platonoff, Frank Lazorthes

Urinary and Sexual Function After Total Mesorectal Excision . . . 196 Christoph A. Maurer

Functional Results of the Colon J-Pouch Versus Transverse Coloplasty Pouch in Heidelberg . . . 205

Alexis Ulrich, Kaspar Z’graggen, Jürgen Weitz, Markus W. Büchler

Indications for Neoadjuvant Long-Term Radiotherapy . . . 212 Lars Påhlman

Neoadjuvant Radiotherapy and Radiochemotherapy for Rectal Cancer . . . . 221 Claus Rödel, Rolf Sauer

Adjuvant Radiochemotherapy for Rectal Cancer . . . 231 Martina Treiber, R. Krempien, H. P. Knaebel, J. Debus

(6)

Contents VII

Intraoperative Radiotherapy for Rectal Carcinoma . . . 238 Martina Treiber, S. Oertel, J. Weitz, R. Krempien, M. Bischof, M. Wannenmacher, M. Büchler, J. Debus

Indications and Effect on Survival of Standard Chemotherapy

in Advanced Colorectal Cancer . . . 245 Birgit Kallinowski

New Chemotherapeutic Strategies in Colorectal Cancer . . . 250 Markus Moehler, Andreas Teufel, Peter R. Galle

Active Specific Immunotherapy in Colon Cancer . . . 260 A. J. M. van den Eertwegh

Radiofrequency Ablation in Metastatic Disease . . . 268 Andreas Lubienski

Riferimenti

Documenti correlati

Some modifiable risk factors that seem to be strong- ly associated with colon cancer are more weakly related to rectal cancer [ 4].. Colorectal cancer (CRC) is a serious global

Perianal Technique for Selected Cases of Early Rectal Cancer High recurrence rates – T 1 18%, T2 47% – are descri- bed in all of these approaches, and survival varies in T 1 from 72

Hida J, Yoshifuji T, Tokoro T et al (2004) Comparison of long-term functional results of colonic J-pouch and straight anastomosis after low anterior resection for rectal cancer:

The robot is first positioned on a level with the left flank, using the trocars in the right iliac fossa and right hypochondrium, and dissection of the left colon is performed..

In the phase II Lyon R 0-04 study [26], 40 operable patients were treated with two cycles of chemothera- py given in weeks 1 and 5, with 130 mg/m 2 oxaliplatin on day 1 followed

Several phase III stud- ies concluded that patients who are treated at diagno- sis of metastatic disease with conventional FU-based regimens live significantly longer (by 3–6

Ernest Miles [ 1] postulated that adequate treatment of rectal cancer, regardless of the site and apparent progress of the tumour, in all cases necessitated a wide excision of

Aaronson NK, Ahmedzai S, Bergman B et al for the European Organization for Research and Treatment of Cancer Study Group on Quality of Life ( 1993) The EORTC QLQ-C 30: a quality of